Page last updated: 2024-12-10

dicyclanil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3081364
SCHEMBL ID120066
MeSH IDM0335940

Synonyms (29)

Synonym
dbc8o809s5 ,
unii-dbc8o809s5
dicyclanil [iso]
2-(cyclopropylamino)-4,6-diamino-5-cyanopyrimidine
5-pyrimidinecarbonitrile, 4,6-diamino-2-(cyclopropylamino)-
dicyclanil
4,6-diamino-2-(cyclopropylamino)-5-pyrimidinecarbonitrile
112636-83-6
4,6-diamino-2-cyclopropylaminopyrimidine-5-carbonitrile
4,6-diamino-2-(cyclopropylamino)pyrimidine-5-carbonitrile
FT-0659945
A802619
AKOS006283479
S4873
SCHEMBL120066
clik
DTXSID5041013
J-514108
J-002806
dicyclanil, pestanal(r), analytical standard
mfcd03095705
dicyclanil 10 microg/ml in acetonitrile
HY-121263
DS-18401
BCP08674
CCG-266503
Q27276312
CS-0081329
4,6-diamino-2-(cyclopropylamino)-pyrimidine-5-carbonitrile

Research Excerpts

Treatment

ExcerptReferenceRelevance
"All dicyclanil treatments gave significant reduction in strike in comparison to controls up until 4 months after crutching but protection in the sheep treated immediately after shearing had waned at 5 months. "( Strategic use of crutching and dicyclanil to protect unmulesed sheep against breech strike.
Brown, GW; Cramp, AP; James, PJ; Mcphie, R; Winkleman, J, 2009
)
1.2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (7.69)18.2507
2000's14 (53.85)29.6817
2010's8 (30.77)24.3611
2020's2 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.88 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index42.91 (26.88)
Search Engine Supply Index3.07 (0.95)

This Compound (26.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (23.08%)5.53%
Reviews1 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (73.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]